Patent US6867248B1 successfully refreshed from Google Patents.
← Back to Patent Explorer
US6867248B1 Expired / Lapsed US ⏱️ 0.0 years remaining

Polyhydroxyalkanoate compositions having controlled degradation rates

Assignee: Tepha Inc
•
Filing: 2003-03-28
•
Granted: 2005-03-15
•
Expires: 2023-03-28
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Biocompatible polyhydroxyalkanoate compositions with controlled degradation rates have been developed. In one embodiment, the polyhydroxyalkanoates contain additives to alter the degradation rates. In another embodiment, the polyhydroxyalkanoates are formed of mixtures of monomers or include pendant groups or modifications in their backbones to alter their degradation rates. In still another embodiment, the polyhydroxyalkanoates are chemically modified. Methods for manufacturing the devices which increase porosity or exposed surface area can be used to alter degradability. For example, as demonstrated by the examples, porous polyhydroxyalkanoates can be made using methods that creates pores, voids, or interstitial spacing, such as an emulsion or spray drying technique, or which incorporate leachable or lyophilizable particles within the polymer. Examples describe poly(4HB) compositions including foams, coatings, meshes, and microparticles. As demonstrated by the examples, these polyhydroxyalkanoate compositions have extremely favorable mechanical properties, as well as are biocompatible and degrade within desirable time frames under physiological conditions. These polyhydroxyalkanoate materials provide a wider range of polyhydroxyalkanoate degradation rates than are currently available. Methods for processing these materials, particularly for therapeutic, prophylactic or diagnostic applications, or into devices which can be implanted or injected, are also described.

Inventors

  • 👤 David P. Martin
  • 👤 Frank Skraly
  • 👤 Simon F. Williams

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 12:17
CPC Classifications
C; C12; C12P; C12P7/00; C12P7/62; C12P7/625; A; A61; A61K; A61K47/00; A61K47/50; A61K47/51; A61K47/56; A61K47/59; A61K47/593; A61K47/69; A61K47/6957; A61K9/00; A61K9/14; A61K9/16; A61K9/1605; A61K9/1629; A61K9/1641; A61K9/1647; A61L; A61L15/00; A61L15/16; A61L15/22; A61L15/26; A61L17/00; A61L17/06; A61L17/10; A61L17/12; A61L24/00; A61L24/001; A61L24/0042; A61L26/00; A61L26/0009; A61L26/0019; A61L26/0061; A61L26/009; A61L27/00; A61L27/14; A61L27/18; A61L27/28; A61L27/34; A61L27/50; A61L27/58; A61L29/00; A61L29/04; A61L29/06; A61L31/00; A61L31/04; A61L31/06; A61L31/14; A61L31/148; C08; C08G; C08G63/00; C08G63/02; C08G63/06; C08G63/64; C08G63/68; C08G63/685; C08G63/6852; C08G63/688; C08G63/6882; C08G63/91; C08G63/912; C08K; C08K5/00; C08K5/0008; C08K5/0033; C12N; C12N5/00; C12N5/0068; C12N2533/00; C12N2533/30

Claims Analysis

Total Claims: 4
Claim 1
Independent Claim 62 words
Methods for processing a biocompatible polyhydroxyalkanoate that has a controlled degradation rate under physiological conditions into a medical device wherein the mass loss, as measured by gas chromatography, is greater than 5% over a six week period in vivo, or wherein the average molecular mass, as measured by gel permeation chromatography, decreases 20% to 50% over a ten week period in vivo.
Claim 2
Dependent Claim 62 words
Methods for processing a biocompatible polyhydroxyalkanoate that has a controlled degradation rate under physiological conditions into a medical device wherein the mass loss, as measured by gas chromatography, is greater than 5% over a six week period in vivo, or wherein the average molecular mass, as measured by gel permeation chromatography, decreases 20% to 50% over a ten week period in vivo.
Claim 3
Dependent Claim 35 words
The methods of claim 1 wherein the processing involves a process from the group consisting of solvent casting, melt processing, fiber processing, fiber spinning, fiber weaving, extrusion, injection molding, compression molding, lamination, and microparticle formation.
Claim 4
Dependent Claim 23 words
The method of claim 1 wherein the mass loss is from about 5% to about 75% over a six week period in vivo.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2008-03-14 2008-09-13 2009-03-15 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2012-03-14 2012-09-13 2013-03-15 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2016-03-14 2016-09-13 2017-03-15 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag